2023 Annual Meeting | C152 - Motor Neuron Disease

Date Wednesday 04/26/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Stephen Goutman, MD, F�鶹��ýӳ��

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should become familiar with ALS diagnostics, management, the latest clinical trials, and controversies.

This program is supported in part by educational grants from Cytokinetics and Amylyx Pharmaceuticals, Inc.

The Academy was solely responsible, with no influence from the industry supporters, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporters with regard to this CME program.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement

Program Level Intermediate

Recommended Audience Resident, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:20 AM EST	Speaker	ALS Diagnosis, Management, and Epidemiology Stephen Goutman, MD, F�鶹��ýӳ��
07:20 AM - 07:40 AM EST	Speaker	The Evolving Landscape of ALS Clinical Trials and Therapeutic Targets Sabrina Paganoni, MD, PhD
07:40 AM - 08:00 AM EST	Speaker	Optimizing ALS Care and Research through Patient Partnerships Richard S. Bedlack, MD, PhD, F�鶹��ýӳ��
08:00 AM - 09:00 AM EST	Discussion	Controversies in ALS Clinical Care and Management: An Interactive Session Stephen Goutman, MD, F�鶹��ýӳ��, Sabrina Paganoni, MD, PhD, Richard S. Bedlack, MD, PhD, F�鶹��ýӳ��

Faculty Disclosures
Stephen Goutman, MD, F�鶹��ýӳ��	Dr. Goutman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Evidera. The institution of Dr. Goutman has received research support from National Institutes of Health. The institution of Dr. Goutman has received research support from ALS Association. The institution of Dr. Goutman has received research support from CDC. Dr. Goutman has received intellectual property interests from a discovery or technology relating to health care.
Sabrina Paganoni, MD, PhD	Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Richard S. Bedlack, MD, PhD, F�鶹��ýӳ��	Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AB Science. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ALS Hope Foundation. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capvision. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carespace. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clene Nanomedicine. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Compassionate Care ALS. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eikonoclastes. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Haim Pharma. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Care Strategy Partners. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for i3 Health. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impossible Dream Machine. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InThought. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kaplan. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeyQuest. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Launch Bio. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH HealthCare. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Med-IQ. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicinova. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurosense. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime �鶹��ýӳ��. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GenieUS Genomics. The institution of Dr. Bedlack has received research support from MediciNova. The institution of Dr. Bedlack has received research support from Healey Center. Dr. Bedlack has received publishing royalties from a publication relating to health care.